Rotavirus vaccines--balancing intussusception risks and health benefits.
作者信息
Glass Roger I, Parashar Umesh D
机构信息
From the Fogarty International Center, National Institutes of Health, Bethesda, MD (R.I.G.); and the National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta (U.D.P.).
出版信息
N Engl J Med. 2014 Feb 6;370(6):568-70. doi: 10.1056/NEJMe1315836. Epub 2014 Jan 14.
Abstract
摘要
相似文献
1
Rotavirus vaccines--balancing intussusception risks and health benefits.
N Engl J Med. 2014 Feb 6;370(6):568-70. doi: 10.1056/NEJMe1315836. Epub 2014 Jan 14.
2
Intussusception and an oral rotavirus vaccine.
N Engl J Med. 2001 Jun 14;344(24):1866; author reply 1866-7.
3
Rotavirus vaccines.
N Engl J Med. 2006 Apr 20;354(16):1747-51; author reply 1747-51.
4
Intussusception and an oral rotavirus vaccine.
N Engl J Med. 2001 Jun 14;344(24):1866; author reply 1866-7. doi: 10.1056/NEJM200106143442412.
5
Rotavirus vaccination and intussusception--act two.
N Engl J Med. 2011 Jun 16;364(24):2354-5. doi: 10.1056/NEJMe1105302.
6
Intussusception following rotavirus vaccination.
Indian Pediatr. 2014 Sep;51(9):758. doi: 10.1007/s13312-014-0497-6.
7
Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.
Lancet Glob Health. 2019 Nov;7(11):e1541-e1552. doi: 10.1016/S2214-109X(19)30412-7.
8
[Merck's oral rotavirus vaccine RotaTeq suspected to cause invagination in infants].
Lakartidningen. 2007;104(9):646.
9
Editorial commentary: intussusception and rotavirus vaccination--balancing risk against benefit.
Clin Infect Dis. 2013 Nov;57(10):1435-7. doi: 10.1093/cid/cit532. Epub 2013 Aug 19.
10
Intussusception alert.
Nursing. 2007 Apr;37(4):10. doi: 10.1097/01.NURSE.0000266004.05955.0b.
引用本文的文献
1
A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response.
Pharmaceutics. 2022 Jul 30;14(8):1597. doi: 10.3390/pharmaceutics14081597.
2
Rotavirus Vaccination Likely to Be Cost Saving to Society in the United States.
Clin Infect Dis. 2021 Oct 20;73(8):1424-1430. doi: 10.1093/cid/ciab442.
3
A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses.
Viruses. 2021 Jan 6;13(1):72. doi: 10.3390/v13010072.
4
Effects of rotavirus NSP4 protein on the immune response and protection of the S-VP8* nanoparticle rotavirus vaccine.
Vaccine. 2021 Jan 8;39(2):263-271. doi: 10.1016/j.vaccine.2020.12.005. Epub 2020 Dec 11.
5
Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice.
Vaccine. 2019 Jul 9;37(30):4103-4110. doi: 10.1016/j.vaccine.2019.05.075. Epub 2019 Jun 11.
6
Bioengineered Norovirus S Nanoparticles as a Multifunctional Vaccine Platform.
ACS Nano. 2018 Nov 27;12(11):10665-10682. doi: 10.1021/acsnano.8b02776. Epub 2018 Sep 25.
7
Epidemiology of intussusception before and after rotavirus vaccine introduction in Fiji.
Sci Rep. 2018 Jul 25;8(1):11194. doi: 10.1038/s41598-018-29515-2.
8
Health impact and cost-effectiveness of a domestically-produced rotavirus vaccine in India: A model based analysis.
PLoS One. 2017 Nov 3;12(11):e0187446. doi: 10.1371/journal.pone.0187446. eCollection 2017.
9
Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus.
Sci Rep. 2016 May 19;6:25735. doi: 10.1038/srep25735.
10
Seasonal Dynamics of the Airborne Bacterial Community and Selected Viruses in a Children's Daycare Center.
PLoS One. 2016 Mar 4;11(3):e0151004. doi: 10.1371/journal.pone.0151004. eCollection 2016.
本文引用的文献
1
Risk of intussusception after monovalent rotavirus vaccination.
N Engl J Med. 2014 Feb 6;370(6):513-9. doi: 10.1056/NEJMoa1311738. Epub 2014 Jan 14.
2
Intussusception risk after rotavirus vaccination in U.S. infants.
N Engl J Med. 2014 Feb 6;370(6):503-12. doi: 10.1056/NEJMoa1303164. Epub 2014 Jan 14.
3
Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.
Clin Infect Dis. 2013 Nov;57(10):1427-34. doi: 10.1093/cid/cit520. Epub 2013 Aug 26.
4
Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012.
Pediatrics. 2013 Jun;131(6):1042-9. doi: 10.1542/peds.2012-2554. Epub 2013 May 13.
5
Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.
Clin Infect Dis. 2013 Jul;57(1):13-20. doi: 10.1093/cid/cit164. Epub 2013 Mar 13.
6
Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States.
J Infect Dis. 2011 Oct 1;204(7):980-6. doi: 10.1093/infdis/jir492. Epub 2011 Aug 29.
7
Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil.
N Engl J Med. 2011 Jun 16;364(24):2283-92. doi: 10.1056/NEJMoa1012952.
8
Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006.
Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S30-4. doi: 10.1097/INF.0b013e3181ffe3eb.
9
Real-world impact of rotavirus vaccination.
Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S1-5. doi: 10.1097/INF.0b013e3181fefa1f.
10
Effect of rotavirus vaccination on death from childhood diarrhea in Mexico.
N Engl J Med. 2010 Jan 28;362(4):299-305. doi: 10.1056/NEJMoa0905211.
Zotero 插件